Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial

被引：0
|
作者：
Ugo De Giorgi
Maddalena Sansovini
Stefano Severi
Silvia Nicolini
Manuela Monti
Giorgia Gurioli
Flavia Foca
Chiara Casadei
Vincenza Conteduca
Monica Celli
Valentina Di Iorio
Daniele Calistri
Federica Matteucci
Finn Edler von Eyben
Gerhardt Attard
Giovanni Paganelli
机构：
[1] IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”,Department of Medical Oncology
[2] IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”,Nuclear Medicine Operative Unit
[3] IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”,Biostatistics and Clinical Trials Unit
[4] IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”,Biosciences Laboratory
[5] IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”,Oncology Pharmacy
[6] Center of Tobacco Control Research,undefined
[7] University College London Cancer Institute,undefined
来源：
British Journal of Cancer | 2021年 / 125卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1226 / 1232
页数：6
相关论文
共 50 条
  • [1] Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial
    De Giorgi, Ugo
    Sansovini, Maddalena
    Severi, Stefano
    Nicolini, Silvia
    Monti, Manuela
    Gurioli, Giorgia
    Foca, Flavia
    Casadei, Chiara
    Conteduca, Vincenza
    Celli, Monica
    Di Iorio, Valentina
    Calistri, Daniele
    Matteucci, Federica
    von Eyben, Finn Edler
    Attard, Gerhardt
    Paganelli, Giovanni
    BRITISH JOURNAL OF CANCER, 2021, 125 (09) : 1226 - 1232
  • [2] Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: results of a phase 2 trial
    Paganelli, G.
    Severi, S.
    Sansovini, M.
    Nicolini, S.
    Grassi, I.
    von Eyben, F.
    Conteduca, V.
    Monti, M.
    Foca, F.
    Gurioli, G.
    Celli, M.
    Matteucci, F.
    De Giorgi, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S487 - S488
  • [3] Circulating androgen receptor (AR) gene amplification and resistance to 177Lu-PSMA-617 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of a phase II clinical trial.
    De Giorgi, Ugo
    Severi, Stefano
    Sarnelli, Anna
    Sansovini, Maddalena
    Monti, Manuela
    Gurioli, Giorgia
    Nicolini, Silvia
    Scarpi, Emanuela
    Casadei, Chiara
    Conteduca, Vincenza
    Matteucci, Federica
    Di Iorio, Valentina
    Amadori, Dino
    Paganelli, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Comment on, 177Lu-PSMA-617 in metastatic, castration-resistant prostate cancer"
    Radtke, Jan Philipp
    Albers, Peter
    Giesel, Frederik Lars
    AKTUELLE UROLOGIE, 2022, 53 (02)
  • [5] VISION trial: 177Lu-PSMA-617 for progressive metastatic castration-resistant prostate cancer
    Rohith, Gorrepati
    INDIAN JOURNAL OF UROLOGY, 2021, 37 (04) : 372 - 373
  • [6] 177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer
    Qu, Gengcuo
    Hua, Qingchu
    Li, Hongmei
    Zhang, Yu
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 152 - 153
  • [7] Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Sun, Michael
    Niaz, Muhammad O.
    Nelson, Adlai
    Skafida, Myrto
    Niaz, Muhammad J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [8] Promising 177Lu-PSMA-617 Therapy Results in Patients with Metastatic Castration-Resistant Prostate Cancer
    Brnjic, Antonio
    Frye, Sarah
    Botkin, Crystal
    Osman, Medhat
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [9] 177Lu-PSMA-617 Treatment of Metastatic Castration-Resistant Prostate Cancer: Efficacy and Survival
    Demirci, E.
    Akyel, R.
    Sahin, O.
    Ocak, M.
    Aygun, A.
    Pehlivanoglu, H.
    Karayel, E.
    Kabasakal, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S202 - S203
  • [10] Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: A substudy of the VISION trial
    Kurth, Jens
    Herrmann, Ken
    Eiber, Matthias
    Rahbar, Kambiz
    Heuschkel, Martin
    Lassmann, Michael
    Jentzen, Walter
    Chicco, Daniela
    Messmann, Richard
    Sartor, A. Oliver
    Morris, Michael J.
    Krause, Bernd J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345